WallStSmart

Calumet Specialty Products Partners (CLMT)vsMP Materials Corp (MP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Calumet Specialty Products Partners generates 1003% more annual revenue ($4.59B vs $416.25M). CLMT leads profitability with a -3.0% profit margin vs -14.6%. CLMT earns a higher WallStSmart Score of 54/100 (C-).

CLMT

Buy

54

out of 100

Grade: C-

Growth: 7.3Profit: 2.0Value: 6.0Quality: 5.0
Piotroski: 5/9Altman Z: 0.84

MP

Avoid

30

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 4.7Quality: 7.5
Piotroski: 4/9Altman Z: 1.51
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CLMT.

MPOvervalued (-13.3%)

Margin of Safety

-13.3%

Fair Value

$44.14

Current Price

$51.08

$6.94 premium

UndervaluedFair: $44.14Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLMT4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
40.8%10/10

Revenue surging 40.8% year-over-year

EPS GrowthGrowth
562.0%10/10

Earnings expanding 562.0% YoY

Debt/EquityHealth
-1.9910/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.658/10

Growing faster than its price suggests

MP1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
119.7%10/10

Revenue surging 119.7% year-over-year

Areas to Watch

CLMT4 concerns · Avg: 1.5/10
Return on EquityProfitability
-1172.0%2/10

ROE of -1172.0% — below average capital efficiency

Altman Z-ScoreHealth
0.842/10

Distress zone — elevated risk

Profit MarginProfitability
-3.0%1/10

Currently unprofitable

Operating MarginProfitability
-4.6%1/10

Operating margin of -4.6%

MP4 concerns · Avg: 2.5/10
Altman Z-ScoreHealth
1.514/10

Distress zone — elevated risk

Return on EquityProfitability
-3.0%2/10

ROE of -3.0% — below average capital efficiency

EPS GrowthGrowth
-55.6%2/10

Earnings declined 55.6%

Free Cash FlowQuality
$-223.49M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CLMT

The strongest argument for CLMT centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 40.8% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bull Case : MP

The strongest argument for MP centers on Revenue Growth. Revenue growth of 119.7% demonstrates continued momentum.

Bear Case : CLMT

The primary concerns for CLMT are Return on Equity, Altman Z-Score, Profit Margin.

Bear Case : MP

The primary concerns for MP are Altman Z-Score, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MP carries more volatility with a beta of 1.95 — expect wider price swings.

MP is growing revenue faster at 119.7% — sustainability is the question.

CLMT generates stronger free cash flow (54M), providing more financial flexibility.

Monitor SPECIALTY CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CLMT scores higher overall (54/100 vs 30/100) and 40.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Calumet Specialty Products Partners

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Calumet Specialty Products Partners, LP produces and sells specialty hydrocarbon products in North America and internationally. The company is headquartered in Indianapolis, Indiana.

MP Materials Corp

BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA

MP Materials Corp. The company is headquartered in Las Vegas, Nevada.

Want to dig deeper into these stocks?